Serologic surveillance of SARS-CoV-2 during the 2020 pandemic in exposed and unexposed healthcare workers in an academic hospital in Amsterdam
- Conditions
- coronaCOVID-19SARS-CoV210047438
- Registration Number
- NL-OMON56239
- Lead Sponsor
- Vrije Universiteit Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 864
1. Individual:
a. health care personnel (physicians and nurses) from participating
hospitals having (or expect within 4 weeks to have) direct patient contact with
patients suspected for COVID-19 or with confirmed COVID-19 disease (exposure
group)
b. control group of health care personnel (administrative, policy and
medical personnel without any patient contact) from participating hospital
without direct contact with patients or contact with patients* direct
environment (e.g. patient room, bed, instruments) (unexposed group)
c: nurses and physicians in direct patiient care for non-COVID-19 patients
2. Informed consent;
3. Age >18 years
1. Insufficient competency in Dutch to such an extent that it prevents
sufficient comprehension of the participant information letter
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>- presence of SARS-CoV-2 antibody (IgM, IgG) titres</p><br>
- Secondary Outcome Measures
Name Time Method <p>Presence of antibodies (IgG) to other corona-viruses<br /><br>Survey information about work conditions, exposures, infection symptoms.<br /><br>B and Tcell reactivity<br /><br>Immune response to vaccine<br /><br>Psychological signs and symptoms<br /><br>Impact of COVID-19 measures on mental health, resilience and job satisfaction.</p><br>